We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
NCI launches exceptional responders initiative: Researchers will attempt to identify why some patients respond to treatment so much better than others.
- Authors
Printz, Carrie
- Abstract
The article focuses on the National Cancer Institute (NCI)'s Exceptional Responders Initiative to understand the molecular reasons behind some patients response to treatment better than others. Topics include the need for developing molecular markers predicting responses of such patients in helping to design more effective treatment programs, the views of Barbara Conley, lead investigator on the same, and the collaboration of NCI with cancer diagnostic firm Foundation Medicine for the same.
- Subjects
NATIONAL Cancer Institute (U.S.); CANCER patients; CANCER treatment; BIOMARKERS; TUMOR markers; CONLEY, Barbara; FOUNDATION Medicine Inc.
- Publication
Cancer (0008543X), 2015, Vol 121, Issue 6, p803
- ISSN
0008-543X
- Publication type
Other
- DOI
10.1002/cncr.29311